Back to Search Start Over

Monkeypox in human pregnancy: an overview

Authors :
Sulaiman Muhammad Daneji, MBBS, FWACS
Aliyu Aminu, MBBS, FMCPath
Awwal Musa Borodo, MBBS, MSc, FWACP, FMCPath
Farouq Muhammad Dayyab, MBBS, MPH, FMCP
Source :
AJOG Global Reports, Vol 2, Iss 4, Pp 100130- (2022)
Publication Year :
2022
Publisher :
Elsevier, 2022.

Abstract

Monkeypox is a viral zoonosis caused by the monkeypox virus, an enveloped, double-stranded DNA virus belonging to the Orthopoxvirus genus in the Poxviridae family. Monkeypox has become a disease of global public health significance. Pregnant women are unfortunately among the those at an increased risk for exposure to monkeypox because their immune system is altered during pregnancy. They may also be at risk for more severe disease or a worse outcome than others. During pregnancy or while breastfeeding when consideration is given for pre-exposure or postexposure vaccination, nonreplicating (Modivied Vaccinia Ankara – Bavarian Nordic) or minimally replicating (LC16, KM Biologics) vaccines are preferred. The ACAM2000 vaccine is contraindicated in pregnancy because it contains live virus particles that can cause fetal vaccinia and fetal death. There are no data to support the use of tecovirimat in pregnant women. However, no fetal adverse effects were noticed when tecovirimat was used in animal studies.

Details

Language :
English
ISSN :
26665778
Volume :
2
Issue :
4
Database :
Directory of Open Access Journals
Journal :
AJOG Global Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.7e01fe9ac8f946e8b03c4de7dca85b52
Document Type :
article
Full Text :
https://doi.org/10.1016/j.xagr.2022.100130